Unitedhealth opened higher at $415.00, compared with its previous close of $410.91. In the last trading session, the stock traded between $406.04 and $416.11. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Unitedhealth is now worth
$ 88.44
resulting in a loss of
$ 11.56 (11.56%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 18 Analysts
Buy
77.78%
Hold
22.22%
Sell
0%
Markets Today
Today's Change
$-3.69 (-0.90%)
Day High
$416.11
Day Low
$406.04
Day Open
$415.00
Prev Close
$410.91
Volume
13,90,000
1W Return
-4.18%
1M Return
8.58%
3M Return
-3.20%
6M Return
9.84%
1Y Return
14.63%
Fundamentals
Market Cap ($ Mn)
3,65,516
PE Ratio
25.27
PB Ratio
3.61
PEG Ratio
48.35
ROE
13.56%
ROCE
9.51%
EPS (TTM)
$6.06
Investment Returns
1 Week
-4.18%
1 Month
8.58%
3 Months
-3.20%
6 Months
9.84%
9 Months
39.32%
Financials
Quarterly
All values in $ Mn
109.6K
Mar 25
111.6K
Jun 25
113.2K
Sep 25
113.2K
Dec 25
111.7K
Mar 26
112.0K
Jun 26
Updates
20Oct
RBC Capital raises UnitedHealth Group price target to $498
RBC Capital raised UnitedHealth Group's price target to $498. The previous price target was set at $478. Analyst Ben Hendrix maintained an Outperform rating on the stock.
10 days ago
16Oct
Bernstein cuts UnitedHealth Group price target to $500, keeps outperform
Bernstein maintains an Outperform rating on UnitedHealth Group. Price target lowered from $512 to $500. Analyst Lance Wilkes issued the revised rating.
13 days ago
16Oct
JP Morgan raises UnitedHealth price target to $524, keeps Overweight
JP Morgan analyst Lisa Gill raised UnitedHealth Group's price target to $524. The new target represents an increase from the previous $516 level. The Overweight rating on the stock was maintained by the analyst.
14 days ago
15Oct
UnitedHealth Q3FY26 results: EPS up 61%, shares rise 3.95%
UnitedHealth Group shares rose 3.95% to $411.23 following strong Q3 earnings. Adjusted EPS reached $4.69, beating the Street estimate of $4.12 by 57 cents. Full-year 2026 adjusted EPS guidance raised to at least $20.50 per share. Raymond James cut price target to $450 citing valuation, maintaining Outperform rating. Medical care ratio improved to 88.4%, aided by $610 million in reserve releases.
14 days ago
14Oct
Piper Sandler raises UnitedHealth Group price target to $504
Piper Sandler raised UnitedHealth Group's price target from $502 to $504. The firm maintained an Overweight rating on the stock. Analyst Jessica Tassan issued the revised price target.
15 days ago
14Oct
Barclays maintains overweight on UnitedHealth Group, cuts target to $440
Barclays maintains an Overweight rating on UnitedHealth Group. Price target lowered from $441 to $440 by analyst Andrew Mok. Rating remains unchanged despite the minor reduction in target price.
